SCHEMBL4993099

SCHEMBL4993099

O=C(O)c1ccn(C(c2ccccc2)c2ccccc2)c(=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.42
PTPRC P08575 2/20 0.41
OPRD1 P41143 1/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PLA2G4A P47712 7/20 0.41
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
CDC25A P30304 1/20 0.39
CDC25B P30305 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PTGS2 P35354 1/20 0.39
ANPEP P15144 1/20 0.38
ENPEP Q07075 1/20 0.38
LTB4R Q15722 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14605313 0.84 TTR (0.40) TTRPTPRCKMT2AMEN1TDP1
SCHEMBL14972192 0.84 ALDH1A1 (0.47) TTRPTPRCKMT2AMEN1TDP1
SCHEMBL14972269 0.84 ALDH1A1 (0.47) TTRPTPRCKMT2AMEN1TDP1
SCHEMBL4986643 0.83 OPRD1 (0.47) OPRD1KMT2AMEN1ALDH1A1MAPT
SCHEMBL2590345 0.77 HCAR3 (0.47) TTRKMT2AMEN1TDP1KDM4E
SCHEMBL4436629 0.75 OPRD1 (0.45) TTRPTPRCOPRD1PLA2G4ALTB4R
SCHEMBL11538981 0.72 GAA (0.43) KMT2AMEN1TDP1ALDH1A1MAPT
SCHEMBL14966610 0.72 HCAR3 (0.46) KMT2AMEN1KDM4EALDH1A1POLB
SCHEMBL3581132 0.72 SMN1; SMN2 (0.56) TTRKMT2AMEN1TDP1KDM4E
SCHEMBL23534363 0.71 PTGS2 (0.43) KMT2AMEN1TDP1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188528-A1 Modulators of C3a receptor and methods of use thereof ENCYSIVE PHARMACEUTICALS, INC. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188528-A1 Modulators of C3a receptor and methods of use thereof C3AR1, C5, C5AR1 TTR 167/4885PTPRC 601/4885OPRD1 1169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.